Economic Analysis of Pharmaceutical R^|^amp;D Policy

Economic Policy Analysis in a Macroeconometric Model for Iran

Economic Analysis of Pharmaceutical Technologies in Modern Beef Production

A General-Equilibrium Analysis of Public Policy for Pharmaceutical Prices

Retail sales of prescription drugs totaled $154.5 billion in 2001. The National Institute for Health Care Management estimates annual sales will exceed $400 billion by the year 2010. This paper analyzes the welfare and distributional effects of two policy families that could be used to cope with high and rising pharmaceutical costs. We employ a general-equilibrium approach to contrast the curre...

Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries

OBJECTIVE To identify pharmaceutical policy changes during the economic recession in eight European countries and to determine whether policy measures resulted in lower sales of, and less expenditure on, pharmaceuticals. METHODS Information on pharmaceutical policy changes between 2008 and 2011 in eight European countries was obtained from publications and pharmaceutical policy databases. Dat...

Public Policy and Pharmaceutical Innovation

Historically, new drug introductions have played a central role in medical progress and the availability of cost-effective therapies. Nevertheless, public policy toward pharmaceuticals has been characterized in recent times by increasingly stringent regulatory controls, shorter effective patent terms, and increased encouragement of generic product usage. This has had an adverse effect on the in...